Fogarty Center Schedules Hybrid Global Health Meeting
Published Date: 10/1/2025
Notice
Summary
The Fogarty International Center Advisory Board will meet on September 10-11, 2026, both in person and online. Part of the meeting on September 10 will be closed to protect private info about grant applications, while the open session on September 11 will share updates on current and future projects. This meeting affects researchers applying for grants and anyone interested in global health research progress.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Grant Applications Reviewed in Closed Session
On September 10, 2026 from 3:00 p.m. to 5:00 p.m., the Fogarty International Center Advisory Board will close the meeting to review and evaluate the second level of grant applications. The closed session is to protect confidential trade secrets, patentable material, and personal information about individuals associated with the applications.
Open Public Session with Project Updates
On September 11, 2026 from 9:00 a.m. to 12:30 p.m., the Fogarty Advisory Board will hold an open session (in person and virtual) to provide updates and discussion of current and planned Fogarty activities. The open portion is available to the public via the Fogarty website and does not require registration.
Accessibility Accommodations Available for Attendees
Individuals who plan to attend in person or view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person in advance. The notice provides a contact (Kristen Weymouth) and instructions for requesting accommodations.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-19150, Agency Information Collection Activity Under OMB Review: Fixed Guideway Capital Investment Grants (CIG) Program Section 5309
The government is reviewing the paperwork rules for the Fixed Guideway Capital Investment Grants program, which helps fund big public transit projects like trains and buses. Transit agencies will need to provide updated info, but this review aims to keep things simple and efficient. The review could affect how quickly money flows for these important transit upgrades.
Next: 2025-19154, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Amended Notice of Meeting
Heads up! The National Advisory Board on Medical Rehabilitation Research meeting has been shortened from two days to just one day on December 1, 2025, now running from 10 a.m. to 4 p.m. This change affects anyone planning to attend or follow the meeting, but no money changes are involved. Mark your calendars for the new, tighter schedule!